AUM$133.4M
Expense Ratio0.50%
NAV$49.88
Holdings103
InceptionDec 30, 2014
Price Chart
Key Statistics
Previous Close
$50.69Day Range
$49.18$50.03
52-Week Range
$23.59$54.18
Avg Volume
24.0KDividend Yield
2.29%Expense Ratio
0.50%AUM
$133.4MShares Outstanding
2.7METF Grades
?Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 83.67% |
| Netherlands | 3.36% |
| Canada | 3.14% |
| Ireland | 3.04% |
| Switzerland | 1.86% |
| Belgium | 1.40% |
| China | 1.39% |
| United Kingdom | 1.27% |
| Germany | 0.87% |
Fund Information
- Issuer
- ALPS Funds
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Dec 30, 2014
- Exchange
- NYSE_ARCA
- Description
- The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Similar ETFs
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $133.4M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 30.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics Inc. | 4.06% | 70,365 | $5.5M |
| 2 | CELC | Celcuity Inc. | 3.40% | 41,241 | $4.6M |
| 3 | CGON | CG oncology Inc. | 3.37% | 71,897 | $4.5M |
| 4 | MIRM | Mirum Pharmaceuticals Inc. | 3.06% | 45,804 | $4.1M |
| 5 | ALKS | Alkermes PLC | 3.03% | 147,168 | $4.1M |
| 6 | XENE | Xenon Pharmaceuticals Inc. | 2.97% | 68,873 | $4.0M |
| 7 | FOLD | Amicus Therapeutics Inc. | 2.94% | 274,988 | $4.0M |
| 8 | APGE | Apogee Therapeutics Inc. | 2.67% | 48,872 | $3.6M |
| 9 | VKTX | Viking Therapeutics Inc. | 2.66% | 100,746 | $3.6M |
| 10 | ACAD | ACADIA Pharmaceuticals Inc. | 2.39% | 150,789 | $3.2M |
| 11 | CRNX | Crinetics Pharmaceuticals Inc. | 2.30% | 84,576 | $3.1M |
| 12 | DNTH | Dianthus Therapeutics Inc. | 2.28% | 38,214 | $3.1M |
| 13 | NAMS | Newamsterdam Pharma Co. NV | 2.24% | 101,063 | $3.0M |
| 14 | GPCR | Structure Therapeutics Inc. | 2.20% | 54,083 | $3.0M |
| 15 | EWTX | Edgewise Therapeutics Inc. | 2.10% | 94,360 | $2.8M |
Page 1 of 3
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.98% | — | ||
| 1W | -2.19% | — | ||
| 1M | -2.62% | — | ||
| 3M | -4.07% | — | ||
| 6M | +31.58% | — | ||
| YTD | -2.15% | — | ||
| 1Y | +58.73% | — | ||
| 3Y | +76.54% | — | ||
| 5Y | -9.55% | — |
Moving Averages
20-Day MA
$50.82
Below 20-Day MA50-Day MA
$51.21
Below 50-Day MA200-Day MA
$41.29
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$54.18
Current Price
$49.18
52-Week Low
$23.59
$23.59$54.18
Current Yield
2.29%
Annual Dividend
$2.0445
Frequency
1x/year
Last Ex-Date
Dec 19, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.1735 | Dec 26, 2024 |
| Dec 21, 2023 | $0.0711 | Dec 27, 2023 |
| Dec 19, 2019 | $0.0158 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 21, 2017 | $0.5795 | Dec 28, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | SBIO | Healthcare(222 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.59% | 0.48% |
| AUM | $133.4M | $1.25B | $639.0M |
| Dividend Yield | 2.29% | 3.24% | 1.61% |
| Avg Volume | 24.0K | 588.6K | 99.0K |
| Holdings | 103 | 172 | 138 |
| Performance | |||
| 1-Month Return | — | -3.19% | -3.32% |
| 6-Month Return | — | +5.94% | +4.37% |
| YTD Return | — | -1.42% | -1.73% |
| 1-Year Return | — | +17.48% | +11.51% |
Compare with Another ETF
Search for an ETF to compare with SBIO: